Jayant Aphale

Overview

Jayant Aphale received $2M in total compensation, including $274K in salary, at Gritstone bio in 2018. Jayant Aphale also received an average of $1M at Sarepta Therapeutics from 2012 to 2015.

Source: SEC filings on April 26, 2019, May 31, 2016, and April 30, 2015.

Related executives

We found 36 more executives who work or worked at Gritstone bio and Sarepta Therapeutics.

Andrew Allen

Gritstone bio

Chief Executive Officer

Karin Jooss

Gritstone bio

Executive Vice President and Head of Research & Development

Erin Jones

Gritstone bio

Chief Operating Officer

Louise Rodino-Klapac

Sarepta Therapeutics

Chief Scientific Officer

Ian Estepan

Sarepta Therapeutics

Chief Financial Officer

Ryan Brown

Sarepta Therapeutics

General Counsel

William Ciambrone

Sarepta Therapeutics

Executive Vice President, Technical Operations

Douglas Ingram

Sarepta Therapeutics

Chief Executive Officer

News

You may also like